AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer

Clinical trial NCT04630756 · COMPLETED

Trial details

NCT number: NCT04630756
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Haematological Malignancies

Start date: 2021-02-17
Primary completion: 2023-09-08
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.